Skip to main content
Top
Published in: CEN Case Reports 2/2018

01-11-2018 | Case Report

Ruptured infected aneurysm of the thoracic aorta associated with tunneled dialysis catheter-related methicillin-resistant Staphylococcus aureus bacteremia in a hemodialysis patient

Authors: Fumiko Katsuragawa, Kiyotaka Nagahama, Shotaro Naito, Yukio Tsuura, Megumi Otani, Takaaki Koide, Sakino Nishiyama, Tomoki Yanagi, Azuma Nanamatsu, Shota Aki, Makoto Aoyagi, Hiroyuki Tanaka, Tatemitsu Rai, Shinichi Uchida

Published in: CEN Case Reports | Issue 2/2018

Login to get access

Abstract

Patients with an indwelling tunneled dialysis catheter (TDC) for hemodialysis access are at a high risk of developing methicillin-resistant Staphylococcus aureus (MRSA) infection. MRSA bacteremia complications rarely include infected aneurysm. Here, we report the first case of an infected thoracic aneurysm associated with TDC-related MRSA bacteremia. An 86-year-old Japanese male with a TDC for hemodialysis access developed TDC-related MRSA bacteremia. Intravenous vancomycin was initiated, and the TDC was removed on day 3. Despite removal of the catheter and initiation of vancomycin treatment, MRSA bacteremia persisted. Chest computed tomography (CT) showed no aneurysm; however, calcification of the thoracic aorta was detected on admission. The patient subsequently developed hemosputum. CT revealed a thoracic aneurysm, which turned out to be caused by MRSA bacteremia. The patient eventually died because of the rupture of the infected aneurysm, as confirmed by autopsy. This report demonstrates TDC management in a patient with TDC-related MRSA bacteremia and the importance of investigating a metastatic infection to a calcified artery if bacteremia persists.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients-United States, 2005. Morb Mortal Wkly Rep. 2007;56:197–9. Centers for Disease Control and Prevention. Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients-United States, 2005. Morb Mortal Wkly Rep. 2007;56:197–9.
2.
go back to reference Launay-Vacher V, Izzedine H, Baumelou A, Deray G. FHD: an index to evaluate drug elimination by hemodialysis. Am J Nephrol. 2005;25:342–51.CrossRefPubMed Launay-Vacher V,  Izzedine H, Baumelou A, Deray G. FHD: an index to evaluate drug elimination by hemodialysis. Am J Nephrol. 2005;25:342–51.CrossRefPubMed
3.
go back to reference Lee CC, Ng YY, Chou YH, et al. Mycotic aneurysm of the abdominal aorta in a patient undergoing hemodialysis: an unusual complication of Staphylococcus aureus bacteremia. Clin Infect Dis. 2000;30:823–4.CrossRefPubMed Lee CC, Ng YY, Chou YH, et al. Mycotic aneurysm of the abdominal aorta in a patient undergoing hemodialysis: an unusual complication of Staphylococcus aureus bacteremia. Clin Infect Dis. 2000;30:823–4.CrossRefPubMed
4.
go back to reference Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779–91.CrossRefPubMed Allon M. Dialysis catheter-related bacteremia: treatment and prophylaxis. Am J Kidney Dis. 2004;44(5):779–91.CrossRefPubMed
5.
go back to reference Center for Disease Control and Prevention. Invasive methicillin-resistant Staphylococcus aureus infection among dialysis patients-United States, 2005. Morb Mortal Wkly Rep. 2007;56(9):197–9. Center for Disease Control and Prevention. Invasive methicillin-resistant Staphylococcus aureus infection among dialysis patients-United States, 2005. Morb Mortal Wkly Rep. 2007;56(9):197–9.
6.
go back to reference Miller LM, Clark E, Dipchand C, et al. Hemodialysis Tunneled Catheter-Related Infections. Can J Kidney Health Dis. 2016;3:1–11. Miller LM, Clark E, Dipchand C, et al. Hemodialysis Tunneled Catheter-Related Infections. Can J Kidney Health Dis. 2016;3:1–11.
7.
go back to reference Chong YP, Park SJ, Kim HS, et al. Persistent Staphylococcus aureus bacteremia. A prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine. 2013;92:98–108.CrossRefPubMedPubMedCentral Chong YP, Park SJ, Kim HS, et al. Persistent Staphylococcus aureus bacteremia. A prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates. Medicine. 2013;92:98–108.CrossRefPubMedPubMedCentral
8.
go back to reference Marr KA, Kong L, Fowler VG, et al. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int. 1998;54:1684–9.CrossRefPubMed Marr KA, Kong L, Fowler VG, et al. Incidence and outcome of Staphylococcus aureus bacteremia in hemodialysis patients. Kidney Int. 1998;54:1684–9.CrossRefPubMed
9.
go back to reference Matsui S, Hatta T. Mycotic abdominal aortic aneurysm in a dialysis patient with catheter-related methicillin-resistant Staphylococcus aureus bacteremia. Ther Apher Dial. 2011;15:113–4.CrossRefPubMed Matsui S, Hatta T. Mycotic abdominal aortic aneurysm in a dialysis patient with catheter-related methicillin-resistant Staphylococcus aureus bacteremia. Ther Apher Dial. 2011;15:113–4.CrossRefPubMed
10.
go back to reference Yoon WJ, Conley A, Herrera S, et al. Ruptured mycotic abdominal aortic pseudoaneurysm in a patient on hemodialysis complicated with oxacillin-resistant Staphylococcus aureus bacteremia. Ann Vasc Surg. 2016;35:204.e1–e4.CrossRef Yoon WJ, Conley A, Herrera S, et al. Ruptured mycotic abdominal aortic pseudoaneurysm in a patient on hemodialysis complicated with oxacillin-resistant Staphylococcus aureus bacteremia. Ann Vasc Surg. 2016;35:204.e1–e4.CrossRef
11.
go back to reference Lopes RJ, Almeida J, Dias PJ, et al. Infectious thoracic aortitis: a literature review. Clin Cardiol. 2009;32:488–90.CrossRefPubMed Lopes RJ, Almeida J, Dias PJ, et al. Infectious thoracic aortitis: a literature review. Clin Cardiol. 2009;32:488–90.CrossRefPubMed
12.
go back to reference Agarwal A, Singh KP, Jain A. Medical significance and management of staphylococcal biofilm. FEMS Immunol Med Microbiol. 2010;58:147–60.CrossRefPubMed Agarwal A, Singh KP, Jain A. Medical significance and management of staphylococcal biofilm. FEMS Immunol Med Microbiol. 2010;58:147–60.CrossRefPubMed
13.
go back to reference Kuypers JM, Proctor RA. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun. 1989;57:2306–12.PubMedPubMedCentral Kuypers JM, Proctor RA. Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun. 1989;57:2306–12.PubMedPubMedCentral
14.
go back to reference Hsu RB, Chen RJ, Wang SS, Chu SH. Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg. 2004;40:30–5.CrossRefPubMed Hsu RB, Chen RJ, Wang SS, Chu SH. Infected aortic aneurysms: clinical outcome and risk factor analysis. J Vasc Surg. 2004;40:30–5.CrossRefPubMed
15.
go back to reference Kondo T, Hirota M, Kondo S, et al. Post-thoracic endovascular aortic repair complicated with mycotic aneurysm rupture, repaired by redo thoracic endovascular aortic repair. Ann Vasc Surg. 2016;33:228.e1–4.CrossRef Kondo T, Hirota M, Kondo S, et al. Post-thoracic endovascular aortic repair complicated with mycotic aneurysm rupture, repaired by redo thoracic endovascular aortic repair. Ann Vasc Surg. 2016;33:228.e1–4.CrossRef
16.
go back to reference Weis-Müller BT, Rascanu C, Sagban A, et al. Single-center experience with open surgical treatment of 36 infected aneurysms of the thoracic, thoracoabdominal, and abdominal aorta. Ann Vasc Surg. 2011;25:1020–5.CrossRefPubMed Weis-Müller BT, Rascanu C, Sagban A, et al. Single-center experience with open surgical treatment of 36 infected aneurysms of the thoracic, thoracoabdominal, and abdominal aorta. Ann Vasc Surg. 2011;25:1020–5.CrossRefPubMed
17.
go back to reference Kan CD, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007;46:906–12.CrossRefPubMed Kan CD, Lee HL, Yang YJ. Outcome after endovascular stent graft treatment for mycotic aortic aneurysm: a systematic review. J Vasc Surg. 2007;46:906–12.CrossRefPubMed
Metadata
Title
Ruptured infected aneurysm of the thoracic aorta associated with tunneled dialysis catheter-related methicillin-resistant Staphylococcus aureus bacteremia in a hemodialysis patient
Authors
Fumiko Katsuragawa
Kiyotaka Nagahama
Shotaro Naito
Yukio Tsuura
Megumi Otani
Takaaki Koide
Sakino Nishiyama
Tomoki Yanagi
Azuma Nanamatsu
Shota Aki
Makoto Aoyagi
Hiroyuki Tanaka
Tatemitsu Rai
Shinichi Uchida
Publication date
01-11-2018
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 2/2018
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-018-0352-z

Other articles of this Issue 2/2018

CEN Case Reports 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine